This inventor holds 1 USPTO granted patent. Top assignee: Massachusetts Institute of Technology. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovations by Martin Wienisch
Introduction
Martin Wienisch is an accomplished inventor based in Arlington, MA (US). He has made significant contributions to the field of genetic engineering, particularly in enhancing chromosomal homologous recombination. His work has implications for disease prevention and therapeutic strategies.
Latest Patents
Wienisch holds a patent titled "Methods of enhancing chromosomal homologous recombination." This patent describes methods that stimulate a loss of heterozygosity at a gene locus of interest in living cells. The methods utilize an enhancer component and a target-specific endonuclease component. Notably, exogenous donor DNA homologous to the gene locus is not introduced into the living cell. The desired allele remains uncleaved, while the undesired allele may be uncleaved, cleaved at a single location, or cleaved at multiple locations. These innovative methods have numerous applications, including the repair of risk alleles for disease prevention, correction of heterozygous mutations in dividing cells, and the design of cancer therapeutics.
Career Highlights
Wienisch is affiliated with the Massachusetts Institute of Technology, where he continues to advance his research. His work is at the forefront of genetic engineering, contributing to the understanding and manipulation of genetic material.
Collaborations
He has collaborated with notable colleagues, including Guoping Feng and Jonathan Wilde, to further enhance the impact of his research.
Conclusion
Martin Wienisch's innovative approaches to enhancing chromosomal homologous recombination represent a significant advancement in genetic engineering. His contributions have the potential to influence various fields, including medicine and biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
